Products
IP Reports
Search
Patexia Concierge
Patent Analyzer
Trademark Analyzer
Litigation Analyzer
All Products
Services
Lateral Opportunities
Expert Witness
Research Studies
Strategic Partnership
All Services
IP Community
IP Community
IP Webinars
In the News
Company
About Us
Press Release
Careers
Contact Us
Search
Login
Join
Patexia
Interest Groups
Message:*
Pharmacokinetics
Summary
Newsfeed
Contests
Connect
Followers
91
Followers
Madhav Kulkarni
Jay Anand Singh
Jacob Vigil
Katyayani Tatiparti
sudhir G
Satheeshkumar
Josseaux Etienne
Sankar Sundaram
Mike Danquah
Jonathan Woodard
See All Followers »
Pharmacokinetics > Nova Content
Alejandro Freixes
Exelixis thyroid cancer drug may get early approval
Alejandro Freixes
Oct 23, 2011
(Reuters) - Exelixis Inc's drug to treat a rare form of thyroid cancer met the main goal of a late-stage study, prompting the company to look to an...
Read More »
-
Oct 23, 2011
Comment:
0
Favorite (
0
)
Technical
Semi-technical
General
«Prev
1
2
3
4
Menu
Log In
Products
IP Reports
Search
Patexia Concierge
Patent Analyzer
Trademark Analyzer
Litigation Analyzer
All Products
Services
Lateral Opportunities
Expert Witness
Research Studies
Strategic Partnership
All Services
IP Community
IP Community
IP Webinars
In the News
Company
About Us
Press Release
Careers
Contact Us